Friday 9 October 2026

One To Watch

Delta-Vir

Company Overview

Want to Update your Company's Profile?


Latest Delta-Vir News

Valneva enters deals with Delta-Vir
13 September 2013
More Delta-Vir news >


Today's issue

Viatris to acquire Pacira BioSciences for $1.65 billion
Pharmaceutical
Viatris to acquire Pacira BioSciences for $1.65 billion
8 October 2026
Pharmaceutical
Zenbexus combo more than doubles median PFS in relapsed myeloma, BMS says
8 October 2026
Biotechnology
Ono Pharma inks license agreement with Biohaven
8 October 2026
Pharmaceutical
Cerevance's solengepras meets endpoint in Phase III Parkinson's trial
8 October 2026
Pharmaceutical
Shionogi transfers MA for Actair in Japan to Ceolia
8 October 2026
Biotechnology
Biohub, US agencies and AI groups commit $1.8 billion to build open data for predictive biology models
8 October 2026
Pharmaceutical
Newron details FDA safety concerns behind evenamide hold, says Phase III continues
8 October 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze